Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study

BACKGROUND: The European Medicines Agency (EMA) requires vaccine manufacturers to conduct enhanced real-time surveillance of seasonal influenza vaccination. The EMA has specified a list of adverse events of interest to be monitored. The EMA sets out 3 different ways to conduct such surveillance: (1)...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lusignan, Simon, Correa, Ana, Dos Santos, Gaël, Meyer, Nadia, Haguinet, François, Webb, Rebecca, McGee, Christopher, Byford, Rachel, Yonova, Ivelina, Pathirannehelage, Sameera, Ferreira, Filipa Matos, Jones, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913774/
https://www.ncbi.nlm.nih.gov/pubmed/31724955
http://dx.doi.org/10.2196/12016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913774/
https://www.ncbi.nlm.nih.gov/pubmed/31724955
http://dx.doi.org/10.2196/12016

Ejemplares similares